Drugs including gliptins, such as exenatide and liraglutide, mimic the action of GLP-1; other drugs, such as sitagliptin and linagliptin, reduce the degradation of GLP-1, being useful in the therapy of diabetes. This evidence concerns the gene GLP1R and diabetes mellitus.